Frequently Asked Questions
The market is segmented based on , By Products (Reagents and Kits, Instruments, Services, and Software), Technology (Mass Spectrometry (MS), Capillary Electrophoresis, Next Generation Sequencing (NGS), Chips And Microarray, Polymerase Chain Reaction (PCR)-Based Methods, Cytogenetics, In Situ Hybridization (ISH or FISH), Molecular Imaging, Others), Application (Oncology, Pharmacogenomics, Microbiology, Prenatal Tests, Tissue Typing, Blood Screening, Cardiovascular Diseases, Neurological Diseases, Infectious Diseases, Others), End User (Hospital, Clinical Laboratories, Academics) – Industry Trends and Forecast to 2030.
.
The Global Molecular Diagnostics Market size was valued at USD 20.10 USD Billion in 2022.
The Global Molecular Diagnostics Market is projected to grow at a CAGR of 13.3% during the forecast period of 2023 to 2030.
The major players operating in the market include F. Hoffmann-La Roche Ltd, Hologic , bioMérieux, Abbott, QIAGEN, Thermo Fisher Scientific, Siemens, Danaher, Myriad Genetics , Illumina , Agilent Technologies , BD, DiaSorin S.p.A, Grifols S.A., Quidel Corporation, Genetic Signatures, MDxHealth , Exact Sciences Corporation, Biocartis, TBG Diagnostics Limited, GenMark Diagnostics , Luminex Corporation, HTG Molecular Diagnostics , Vela Diagnostics, Amoy Diagnostics Co. , Molbio Diagnostics Pvt. , geneOmbio,.
The market report covers data from the U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
